Literature DB >> 23789790

The cross-cultural equivalence of participation instruments: a systematic review.

S A M Stevelink1, W H van Brakel.   

Abstract

PURPOSE: Concepts such as health-related quality of life, disability and participation may differ across cultures. Consequently, when assessing such a concept using a measure developed elsewhere, it is important to test its cultural equivalence. Previous research suggested a lack of cultural equivalence testing in several areas of measurement. This paper reviews the process of cross-cultural equivalence testing of instruments to measure participation in society.
METHODS: An existing cultural equivalence framework was adapted and used to assess participation instruments on five categories of equivalence: conceptual, item, semantic, measurement and operational equivalence. For each category, several aspects were rated, resulting in an overall category rating of 'minimal/none', 'partial' or 'extensive'. The best possible overall study rating was five 'extensive' ratings. Articles were included if the instruments focussed explicitly on measuring 'participation' and were theoretically grounded in the ICIDH(-2) or ICF. Cross-validation articles were only included if it concerned an adaptation of an instrument developed in a high or middle-income country to a low-income country or vice versa.
RESULTS: Eight cross-cultural validation studies were included in which five participation instruments were tested (Impact on Participation and Autonomy, London Handicap Scale, Perceived Impact and Problem Profile, Craig Handicap Assessment Reporting Technique, Participation Scale). Of these eight studies, only three received at least two 'extensive' ratings for the different categories of equivalence. The majority of the cultural equivalence ratings given were 'partial' and 'minimal/none'. The majority of the 'none/minimal' ratings were given for item and measurement equivalence.
CONCLUSION: The cross-cultural equivalence testing of the participation instruments included leaves much to be desired. A detailed checklist is proposed for designing a cross-validation study. Once a study has been conducted, the checklist can be used to ensure comprehensive reporting of the validation (equivalence) testing process and its results. IMPLICATIONS FOR REHABILITATION: • Participation instruments are often used in a different cultural setting than initial developed for. • The conceptualization of participation may vary across cultures. Therefore, cultural equivalence – the extent to which an instrument is equally suitable for use in two or more cultures – is an important concept to address. • This review showed that the process of cultural equivalence testing of the included participation instruments was often addressed insufficiently. • Clinicians should be aware that application of participations instruments in a different culture than initially developed for needs prior testing of cultural validity in the next context.

Entities:  

Mesh:

Year:  2013        PMID: 23789790     DOI: 10.3109/09638288.2012.731132

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  22 in total

1.  Psychometric Evaluation of the Persian Version of the Chronic Illness Anticipated Stigma Scale (CIASS).

Authors:  Ali-Akbar Nejatisafa; Sahar Mozafari; Ahmad-Ali Noorbala; Fatemeh Sadat Asgarian; Valerie A Earnshaw; Mohammad-Ali Sahraian; Farnaz Etesam
Journal:  Int J Behav Med       Date:  2017-08

Review 2.  Symptom management in Chinese adults with end stage renal disease (ESRD).

Authors:  Nicole Levy; Wing Cheung; Haley McDonald; Mara Chris Banez; Jingjing Shang; Patricia W Stone; Carolyn Sun
Journal:  Appl Nurs Res       Date:  2021-11-26       Impact factor: 2.257

3.  People infer communicative action through an expectation for efficient communication.

Authors:  Amanda Royka; Annie Chen; Rosie Aboody; Tomas Huanca; Julian Jara-Ettinger
Journal:  Nat Commun       Date:  2022-07-18       Impact factor: 17.694

4.  Establishing the Cultural Equivalence of the Young Children's Participation and Environment Measure (YC-PEM) for Use in Singapore.

Authors:  Chun Yi Lim; Mary Law; Mary Khetani; Nancy Pollock; Peter Rosenbaum
Journal:  Phys Occup Ther Pediatr       Date:  2015-12-07       Impact factor: 2.360

5.  Provision and uptake of routine antenatal services: a qualitative evidence synthesis.

Authors:  Soo Downe; Kenneth Finlayson; Özge Tunçalp; Ahmet Metin Gülmezoglu
Journal:  Cochrane Database Syst Rev       Date:  2019-06-12

6.  The cultural validation of two scales to assess social stigma in leprosy.

Authors:  Ruth M H Peters; Wim H Van Brakel; Marjolein B M Zweekhorst; Rita Damayanti; Joske F G Bunders
Journal:  PLoS Negl Trop Dis       Date:  2014-11-06

7.  Cultural adaptation of a pediatric functional assessment for rehabilitation outcomes research.

Authors:  Kristen E Arestad; David MacPhee; Chun Y Lim; Mary A Khetani
Journal:  BMC Health Serv Res       Date:  2017-09-15       Impact factor: 2.655

8.  Psychometric properties of the participation scale among former buruli ulcer patients in Ghana and Benin.

Authors:  Janine de Zeeuw; Marlies Douwstra; Till F Omansen; Ghislain E Sopoh; Christian Johnson; Richard O Phillips; Marike Alferink; Paul Saunderson; Tjip S Van der Werf; Pieter U Dijkstra; Ymkje Stienstra
Journal:  PLoS Negl Trop Dis       Date:  2014-11-13

Review 9.  The quality of systematic reviews of health-related outcome measurement instruments.

Authors:  C B Terwee; C A C Prinsen; M G Ricci Garotti; A Suman; H C W de Vet; L B Mokkink
Journal:  Qual Life Res       Date:  2015-09-07       Impact factor: 4.147

10.  Measurement of maternal functioning during pregnancy and postpartum: findings from the cross-sectional WHO pilot study in Jamaica, Kenya, and Malawi.

Authors:  Jenny A Cresswell; Kelli D Barbour; Doris Chou; Affette McCaw-Binns; Veronique Filippi; Jose Guilherme Cecatti; Maria Barreix; Max Petzold; Nenad Kostanjsek; Sara Cottler-Casanova; Lale Say
Journal:  BMC Pregnancy Childbirth       Date:  2020-09-07       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.